[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zevra Therapeutics Inc (ZVRA)

Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zevra Therapeutics Inc 101 Federal Street Boston MA 02110 USA

https://zevra.com Employees: 61 P: 888-958-1253

Sector:

Medical

Description:

Zevra Therapeutics is a rare disease company melding science, data, and patient need to create transformational therapies for diseases with limited or no treatment options. Zevra Therapeutics, formerly known as KemPharm Inc., is based in CELEBRATION, Fla.

Key Statistics

Overview:

Market Capitalization, $K 597,653
Enterprise Value, $K 597,173
Shares Outstanding, K 59,115
Float, K 57,696
% Float 97.60%
Short Interest, K 4,439
Short Float 7.51%
Days to Cover 4.82
Short Volume Ratio 0.59
% of Insider Shareholders 2.40%
% of Institutional Shareholders 35.03%

Financials:

Annual Sales, $ 106,470 K
Annual Net Income, $ 83,230 K
Last Quarter Sales, $ 34,130 K
Last Quarter Net Income, $ 12,160 K
EBIT, $ -370 K
EBITDA, $ 59,270 K

Growth:

1-Year Return 39.16%
3-Year Return 87.22%
5-Year Return 3.91%
5-Year Revenue Growth 701.13%
5-Year Earnings Growth 93.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.16 on 03/09/26
Next Earnings Date 05/06/26 [AMC]
Earnings Per Share ttm 1.03
EPS Growth vs. Prev Qtr 11,700.00%
EPS Growth vs. Prev Year 273.13%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-16 on 12/28/20

ZVRA Ratios

Ratio
Price/Earnings ttm 10.18
Price/Earnings forward 23.71
Price/Earnings to Growth N/A
Return-on-Equity % 57.42%
Return-on-Assets % 26.03%
Profit Margin % 78.17%
Debt/Equity 0.40
Price/Sales 5.82
Price/Cash Flow 11.09
Price/Book 3.82
Book Value/Share 2.75
Interest Coverage 11.86
60-Month Beta 0.89
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.